Autoreactive T cells promote post-traumatic healing in the central nervous system

Journal of Neuroimmunology

Volumn 134, Issue 1-2, 2003, Pages 25-34

  Hofstetter, Harald H ^a   Sewell, Diane L ^b   Liu, Frances ^b   Sandor, Matyas ^b   Forsthuber, Thomas ^a   Lehmann, Paul V ^a   Fabry, Zsuzsa ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Central nervous system; Cytokines; Experimental allergic encephalomyelitis; Myelin oligodendrocyte antigen; Post traumatic healing; Th1 Th2

Indexed keywords

MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PERTUSSIS TOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; BLOOD BRAIN BARRIER; BRAIN INJURY; BRAIN PROTECTION; CONTROLLED STUDY; FEMALE; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVASCULARIZATION; TISSUE REPAIR;

ANIMALS; AUTOIMMUNITY; BLOOD-BRAIN BARRIER; BRAIN INJURIES; CD4-POSITIVE T-LYMPHOCYTES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FREUND'S ADJUVANT; GLYCOPROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PEPTIDE FRAGMENTS; PERTUSSIS TOXIN; TH1 CELLS; TH2 CELLS; WOUND HEALING;

EID: 0037223515     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(02)00358-2     Document Type: Article

References (57)

1. Abbas A.K., Murphy K.M., Sher A. Functional diversity of helper T lymphocytes. Nature. 383:1996;787-793.
2. Abdul-Majid K., Jirholt J., Stadelmann C., Stefferl A., Kjellen P., Wallstrom E., Holmdahl R., Lassmann H., Olsson T., Harris R.A. Screening of several H-2 congenic mouse strains identified H-2(q) mice as highly susceptible to MOG-induced EAE with minimal adjuvant requirement [In Process Citation]. J. Neuroimmunol. 111:2000;23-33.
3. Anderson A.C., Nicholson L.B., Legge K.L., Turchin V., Zaghouani H., Kuchroo V.K. High frequency of autoreactive myelin proteolipid protein-specific T cells in the periphery of naive mice: mechanisms of selection of the self-reactive repertoire. J. Exp. Med. 191:2000;761-770.
4. Arimoto H., Tanuma N., Jee Y., Miyazawa T., Shima K., Matsumoto Y. Analysis of experimental autoimmune encephalomyelitis induced in F344 rats by pertussis toxin administration. J. Neuroimmunol. 104:2000;15-21.
5. Bauer J., Bradl M., Hickley W.F., Forss-Petter S., Breitschopf H., Linington C., Wekerle H., Lassmann H. T-cell apoptosis in inflammatory brain lesions: destruction of T cells does not depend on antigen recognition [see comments]. Am. J. Pathol. 153:1998;715-724.
6. Becker K.J., McCarron R.M., Ruetzler C., Laban O., Sternberg E., Flanders K.C., Hallenbeck J.M. Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia. Proc. Natl. Acad. Sci. U. S. A. 94:1997;10873-10878.
7. Blankenhorn E.P., Butterfield R.J., Rigby R., Cort L., Giambrone D., McDermott P., McEntee K., Solowski N., Meeker N.D., Zachary J.F., Doerge R.W., Teuscher C. Genetic analysis of the influence of pertussis toxin on experimental allergic encephalomyelitis susceptibility: an environmental agent can override genetic checkpoints. J. Immunol. 164:2000;3420-3425.
8. Brabb T., Goldrath A.W., von Dassow P., Paez A., Liggitt H.D., Goverman J. Triggers of autoimmune disease in a murine TCR-transgenic model for multiple sclerosis. J. Immunol. 159:1997;497-507.
9. Brocke S., Gijbels K., Allegretta M., Ferber I., Piercy C., Blankenstein T., Martin R., Utz U., Karin N., Mitchell D. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein [published erratum appears in Nature 1998 April 9;392(6676):630]. Nature. 379:1996;343-346.
10. Brosnan C.F., Bornstein M.B., Bloom B.R. The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis. J. Immunol. 126:1981;614-620.
11. Cancilla P.A., DeBault L.E. Freeze injury and repair of cerebral microvessels. Adv. Exp. Med. Biol. 131:1980;257-269.
12. Cancilla P.A., Frommes S.P., Kahn L.E., DeBault L.E. Regeneration of cerebral microvessels: a morphologic and histochemical study after local freeze-injury. Lab. Invest. 40:1979;74-82.
13. Cyster J.G., Goodnow C.C. Pertussis toxin inhibits migration of B and T lymphocytes into splenic white pulp cords. J. Exp. Med. 182:1995;581-586.
14. Efron J.E., Frankel H.L., Lazarou S.A., Wasserkrug H.L., Barbul A. Wound healing and T-lymphocytes. J. Surg. Res. 48:1990;460-463.
15. Ehrlich P. On immunity with special reference to cell life. Proc. R. Soc. Lond., Biol. 66:1900;424.
16. Eugster H.P., Frei K., Kopf M., Lassmann H., Fontana A. IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur. J. Immunol. 28:1998;2178-2187.
17. Ferber I.A., Brocke S., Taylor-Edwards C., Ridgway W., Dinisco C., Steinman L., Dalton D., Fathman C.G. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156:1996;5-7.
18. Forsthuber T., Yip H.C., Lehmann P.V. Induction of TH1 and TH2 immunity in neonatal mice [see comments]. Science. 271:1996;1728-1730.
19. Fukushi J., Morisaki T., Shono T., Nishie A., Torisu H., Ono M., Kuwano M. Novel biological functions of interleukin-4: formation of tube-like structures by vascular endothelial cells in vitro and angiogenesis in vivo. Biochem. Biophys. Res. Commun. 250:1998;444-448.
20. Goverman J., Woods A., Larson L., Weiner L.P., Hood L., Zaller D.M. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell. 72:1993;551-560.
21. Grenier-Brossette N., Bourget I., Breittmayer J.P., Ferrua B., Fehlmann M., Cousin J.L. Pertussis toxin-induced mitogenesis in human T lymphocytes. Immunopharmacology. 21:1991;109-119.
22. Hancock W.W., Buelow R., Sayegh M.H., Turka L.A. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat. Med. 4:1998;1392-1396.
23. Heeger P.S., Forsthuber T., Shive C., Biekert E., Genain C., Hofstetter H.H., Karulin A., Lehmann P.V. Revisiting tolerance induced by autoantigen in incomplete Freund's adjuvant. J. Immunol. 164:2000;5771-5781.
24. Hinrichs D.J., Wegmann K.W., Dietsch G.N. Transfer of experimental allergic encephalomyelitis to bone marrow chimeras. Endothelial cells are not a restricting element. J. Exp. Med. 166:1987;1906-1911.
25. Janeway C.A. Jr. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol. Today. 13:1992;11-16.
26. Karulin A.Y., Hesse M.D., Tary-Lehmann M., Lehmann P.V. Single-cytokine-producing CD4 memory cells predominate in type 1 and type 2 immunity. J. Immunol. 164:2000;1862-1872.
27. Kelso A. Th1 and Th2 subsets: paradigms lost? Immunol. Today. 16:1995;374-379.
28. Kerlero de Rosbo N., Mendel I., Ben-Nun A. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes. Eur. J. Immunol. 25:1995;985-993.
29. Kerschensteiner M., Gallmeier E., Behrens L., Leal V.V., Misgeld T., Klinkert W.E., Kolbeck R., Hoppe E., Oropeza-Wekerle R.L., Bartke I., Stadelmann C., Lassmann H., Wekerle H., Hohlfeld R. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J. Exp. Med. 189:1999;865-870.
30. Khoruts A., Miller S.D., Jenkins M.K. Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced by effector Th1 cells. J. Immunol. 155:1995;5011-5017.
31. Krakowski M., Owens T. Interferon-gamma confers resistance to experimental allergic encephalomyelitis. Eur. J. Immunol. 26:1996;1641-1646.
32. Kumar R., Yoneda J., Bucana C.D., Fidler I.J. Regulation of distinct steps of angiogenesis by different angiogenic molecules. Int. J. Oncol. 12:1998;749-757.
33. Lafaille J.J., Keere F.V., Hsu A.L., Baron J.L., Haas W., Raine C.S., Tonegawa S. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J. Exp. Med. 186:1997;307-312.
34. Lee J.M., Olitzky P.K. Simple method for enhancing development of acute disseminated encephalomyelitis in mice. Proc. Soc. Exp. Biol. Med. 89:1955;263.
35. Lehmann P.V., Targoni O.S., Forsthuber T.G. Shifting T-cell activation thresholds in autoimmunity and determinant spreading. Immunol. Rev. 164:1998;53-61.
36. Limmer A., Sacher T., Alferink J., Kretschmar M., Schonrich G., Nichterlein T., Arnold B., Hammerling G.J. Failure to induce organ-specific autoimmunity by breaking of tolerance: importance of the microenvironment. Eur. J. Immunol. 28:1998;2395-2406.
37. Liu J., Marino M.W., Wong G., Grail D., Dunn A., Bettadapura J., Slavin A.J., Old L., Bernard C.C. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat. Med. 4:1998;78-83.
38. Matzinger P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12:1994;991-1045.
39. Mendel Kerlero de Rosbo N., Ben-Nun A. Delineation of the minimal encephalitogenic epitope within the immunodominant region of myelin oligodendrocyte glycoprotein: diverse V beta gene usage by T cells recognizing the core epitope encephalitogenic for T cell receptor V beta b and T cell receptor V beta a H-2b mice. Eur. J. Immunol. 26:1996;2470-2479.
40. Moalem G., Leibowitz-Amit R., Yoles E., Mor F., Cohen I.R., Schwartz M. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat. Med. 5:1999;49-55.
41. Motro B., Itin A., Sachs L., Keshet E. Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 87:1990;3092-3096.
42. Oury T.D., Piantadosi C.A., Crapo J.D. Cold-induced brain edema in mice. Involvement of extracellular superoxide dismutase and nitric oxide. J. Biol. Chem. 268:1993;15394-15398.
43. Pakala S.V., Kurrer M.O., Katz J.D. T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice. J. Exp. Med. 186:1997;299-306.
44. Pender M.P., Nguyen K.B., McCombe P.A., Kerr J.F. Apoptosis in the nervous system in experimental allergic encephalomyelitis. J. Neurol. Sci. 104:1991;81-87.
45. Ransohoff R.M., Tani M. Do chemokines mediate leukocyte recruitment in post-traumatic CNS inflammation? Trends Neurosci. 21:1998;154-159.
46. Rapalino O., Lazarov-Spiegler O., Agranov E., Velan G.J., Yoles E., Fraidakis M., Solomon A., Gepstein R., Katz A., Belkin M., Hadani M., Schwartz M. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat. Med. 4:1998;814-821.
47. Rocken M., Racke M., Shevach E.M. IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. Immunol. Today. 17:1996;225-231.
48. Ryan M., McCarthy L., Rappuoli R., Mahon B.P., Mills K.H. Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7-1, B7-2 and CD28. Int. Immunol. 10:1998;651-662.
49. Steinman L. Escape from "horror autotoxicus": pathogenesis and treatment of autoimmune disease. Cell. 80:1995;7-10.
50. Storch M.K., Stefferl A., Brehm U., Weissert R., Wallstrom E., Kerschensteiner M., Olsson T., Linington C., Lassmann H. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol. 8:1998;681-694.
51. Sudweeks J.D., Todd J.A., Blankenhorn E.P., Wardell B.B., Woodward S.R., Meeker N.D., Estes S.S., Teuscher C. Locus controlling Bordetella pertussis-induced histamine sensitization (Bphs), an autoimmune disease-susceptibility gene, maps distal to T-cell receptor beta-chain gene on mouse chromosome 6. Proc. Natl. Acad. Sci. U. S. A. 90:1993;3700-3704.
52. Swartz K.R., Liu F., Sewell D., Schochet T., Campbell I., Sandor M., Fabry Z. Interleukin-6 promotes post-traumatic healing in the central nervous system. Brain Res. 896:2001;86-95.
53. Targoni O.S., Lehmann P.V. Endogenous myelin basic protein inactivates the high avidity T cell repertoire. J. Exp. Med. 187:1998;2055-2063.
54. Torre D., Ferrario G., Bonetta G., Perversi L., Speranza F. In vitro and in vivo induction of nitric oxide by murine macrophages stimulated with Bordetella pertussis. FEMS Immunol. Med. Microbiol. 13:1996;95-99.
55. Willenborg D.O., Fordham S., Bernard C.C., Cowden W.B., Ramshaw I.A. IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157:1996;3223-3227.
56. Woiciechowsky C., Asadullah K., Nestler D., Eberhardt B., Platzer C., Schoning B., Glockner F., Lanksch W.R., Volk H.D., Docke W.D. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury [see comments]. Nat. Med. 4:1998;808-813.
57. Yip H.C., Karulin A.Y., Tary-Lehmann M., Hesse M.D., Radeke H., Heeger P.S., Trezza R.P., Heinzel F.P., Forsthuber T., Lehmann P.V. Adjuvant-guided type-1 and type-2 immunity: infectious/noninfectious dichotomy defines the class of response. J. Immunol. 162:1999;3942-3949.